2020Virology & MycologyRequires access

Aspergillosis: Causes, Forms, and Medication; A Fungal Infection

Neelam Sharma-Walia

Open publisher page 0 citations

Abstract

Aspergillus is a ubiquitous mould genus typically found in soil and rotting vegetation. Sources, modes and treatment. In defining the diseases caused by Aspergillus, the term' aspergillosis 'is used but most generally refers to those caused by Aspergillus fumigatus. Aspergillus flavus, Aspergillus terreus and Aspergillus niger are other animals that can cause human illness [1]. Aspergillus releases massive numbers of conidia (asexual spores) into the air as part of its life cycle and can thus be present in both outdoor and indoor environments. Aspergillus conidia inhalation is normally a daily phenomenon, but only a limited number of individuals experience chronic illness and are at an elevated risk of aspergillosis (e.g. people with compromised immune systems and/or impaired lungs). It is difficult to quantify the burden of aspergillosis in the UK because of the insensitivity of fungal culture, the lack of regular, sensitive, non-culture diagnostic testing and the lack of a national surveillance network. A 2017 study estimated that 3,288-4,257 cases of invasive aspergillosis, up to 3,600 cases of recurrent pulmonary aspergillosis and 110,667-235,070 cases of allergic bronchopulmonary aspergillosis (ABPA) complicating asthma or cystic fibrosis are registered every year in the UK [2].

About this research paper

What this paper is about

Aspergillus is a ubiquitous mould genus typically found in soil and rotting vegetation. Sources, modes and treatment. In defining the diseases caused by Aspergillus, the term' aspergillosis 'is used but most generally refers to those caused by Aspergillus fumigatus. Aspergillus flavus, Aspergillus terreus and Aspergillus niger are other animals that can cause human illness [1]. Aspergillus releases massive numbers of conidia (asexual spores) into the air as part of its life cycle and can thus be present in both outdoor and indoor environments. Aspergillus conidia inhalation is normally a daily phenomenon, but only a limited number of individuals experience chronic illness and are at an elevated risk of aspergillosis (e.g. people with compromised immune systems and/or impaired lungs). It is difficult to quantify the burden of aspergillosis in the UK because of the insensitivity of fungal culture, the lack of regular, sensitive, non-culture diagnostic testing and the lack of a national surveillance network. A 2017 study estimated that 3,288-4,257 cases of invasive aspergillosis, up to 3,600 cases of recurrent pulmonary aspergillosis and 110,667-235,070 cases of allergic bronchopulmonary aspergillosis (ABPA) complicating asthma or cystic fibrosis are registered every year in the UK [2].

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aspergillus is a ubiquitous mould genus typically found in soil and rotting vegetation. Sources, modes and treatment. In defining the diseases caused by Aspergillus, the term' aspergillosis 'is used but most generally refers to those caused by Aspergillus fumigatus. Aspergillus flavus, Aspergillus terreus and Aspergillus niger are other animals that can cause human illness [1]. Aspergillus releases massive numbers of conidia (asexual spores) into the air as part of its life cycle and can thus be present in both outdoor and indoor environments. Aspergillus conidia inhalation is normally a daily phenomenon, but only a limited number of individuals experience chronic illness and are at an elevated risk of aspergillosis (e.g. people with compromised immune systems and/or impaired lungs). It is difficult to quantify the burden of aspergillosis in the UK because of the insensitivity of fungal culture, the lack of regular, sensitive, non-culture diagnostic testing and the lack of a national surveillance network. A 2017 study estimated that 3,288-4,257 cases of invasive aspergillosis, up to 3,600 cases of recurrent pulmonary aspergillosis and 110,667-235,070 cases of allergic bronchopulmonary aspergillosis (ABPA) complicating asthma or cystic fibrosis are registered every year in the UK [2].

Key concepts: Aspergillus, Aspergillosis, Allergic bronchopulmonary aspergillosis, Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, Biology, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Aspergillosis: Causes, Forms, and Medication; A Fungal Infection — Research Paper | ScholarLens